Oncology Nurse Advisor Institute Spotlight Course

Advances in Frontline NSCLC Treatment: Reinforcing the Oncology Nursing Role in the Use of Immune Checkpoint Inhibitor-Based Regimens

1.00 CNE: Immune checkpoint inhibitor regimens for NSCLC continue to evolve. Learn about the latest indications and managing associated immune-related adverse events. Exp 6/27/24

Featured Courses

Relapsed or Refractory Multiple Myeloma: Integrating Recent Advances Into Your Practice

1.00 CME CE: Provides healthcare providers with an ability to individualize treatment plans for patients with relapsed or refractory multiple myeloma. Exp 10/31/24

BCMA-Directed Therapies: Improving Outcomes of Patients with Relapsed/Refractory Multiple Myeloma

1.00 CME CE: Provides expert insight and practical strategies on how to incorporate BCMA-targeted therapies into the treatment strategy for relapsed/refractory multiple myeloma. Exp 8/22/24

How I Treat Paroxysmal Nocturnal Hemoglobinuria (PNH)

1.00 CME: Expert faculty discuss differing treatment strategies for patients with PNH in this point-counterpoint digital activity highlighting factors underlying selection of C5 or C3 inhibitors. Exp 6/30/24

Therapeutic Advancements for the Treatment of High-Risk MDS: Future Opportunities to Improve Patient Survival and Quality of Life

1.00 CME CE: This self-directed education with expert insights answers important questions about MDS risk assessment and emerging therapies for high-risk MDS. Exp 10/27/24

Improving Patient Outcomes Via Novel Immunotherapy Treatment Options for Large B-Cell Lymphoma

1.00 CME CE: Discusses recently approved agents as well as investigational agents in the treatment of Large B- Cell Lymphoma to provide the best outcomes. Exp 10/12/24

Improving Bladder Cancer Survival by Integrating New Knowledge into Clinical Practice

1.00 CME CE: Highlights the evolution of care for bladder cancer and provides an expert-led guide to treatment options for first-line therapy and beyond. Exp 5/9/24

A Global Spotlight on CLL: Shifting Strategies and Optimizing Outcomes

1.00 CME CE: Webcast illuminates the integration of emerging data into everyday clinical workflows to improve therapeutic management of patients with CLL. Exp 9/11/24

Low-risk Myelodysplastic Syndromes in Community Practice: How Recent Advances Will Benefit Your Patients

1.00 CME CE: Offers comprehensive understanding of the appropriate diagnosis, risk stratification, and clinical utility of newer agents for patients with MDS. Exp 4/19/24

Advancing the Treatment of Patients With Myelofibrosis

1.00 CME CE: Drs. Gerds and Grunwald discuss burden of myelofibrosis, molecular abnormalities, pharmacologic options, and emerging novel therapies. Exp 4/30/24

Decoding Clinical Trial Data and Real-World Evidence in mBC with a Focus on Individualized Care

0.75 CME CE: In this 45-minute interactive CME Outfitters Snack, faculty will discuss the evolving treatment landscape of metastatic breast cancer. Exp 5/30/24

Immunotherapy in Upper GI Cancers: A Multidisciplinary Discussion of the Data and Real-World Barriers Faced in Practice

1.00 CME CE: This one-hour program explores real-world applications of data to practice on the immunotherapy terrain in upper GI cancer settings. Exp. 7/31/24